99m Technetium labeled RBC scintigraphy is PRIMARILY used in the diagnosis of
In radionuclide imaging, the most useful radiopharmaceutical for skeletal imaging is:
A lady presented with a 4 cm tumor in the left parietal lobe for which she underwent surgery and radiotherapy. After 3 months she presented with headache and vomiting. Which of the following would characterize the lesion in the patient?
Which common tracer in PET is usually administered in the form of a glucose sugar?
Which radioisotope is PRIMARILY used for detecting acute myocardial infarction rather than assessing myocardial perfusion?
In a child, non-functioning kidney is best diagnosed by:
MUGA scan is not useful in:
Tc-labeled RBCs are used for all except:
Which one of the following imaging modalities is most sensitive for localizing extra-adrenal pheochromocytoma?
A young male patient presents with dyspnea; auscultation reveals absent breath sounds on the right side, and he has hypotension. What is the immediate next step?
Explanation: ***GI Bleeding*** - Technetium-99m labeled RBC scintigraphy (**<sup>99m</sup>Tc-RBC scan**) is highly sensitive for detecting **active gastrointestinal bleeding**, especially slow or intermittent bleeding. - The labeled red blood cells extravasate at the site of bleeding, accumulating and outlining the bleeding focus over time. *Hepatoma* - **Hepatoma** (hepatocellular carcinoma) is primarily diagnosed using imaging modalities like **CT, MRI**, and **ultrasound**, often with contrast enhancement. - While nuclear medicine scans like **FDG-PET** can be used in some cases for staging or assessing viability, <sup>99m</sup>Tc-RBC scans are not a primary diagnostic tool for hepatoma. *Left ventricular function wall motion* - **Left ventricular function** and **wall motion abnormalities** are typically assessed using **echocardiography**, cardiac **MRI**, or **nuclear cardiology studies** like **SPECT** or **PET** using tracers that localize in the myocardium (e.g., <sup>99m</sup>Tc-Sestamibi or Thallium-201). - <sup>99m</sup>Tc-RBC scans are sometimes used for **gated blood pool scans** to assess global ejection fraction, but not directly for wall motion analysis in the same way as other dedicated cardiac modalities. *Hepatic hemangioma* - **Hepatic hemangiomas** can be characterized by **<sup>99m</sup>Tc-RBC scintigraphy**, which shows **early photopenia** followed by **delayed fill-in and retention** of the tracer due to the characteristic slow blood flow within these benign vascular tumors. - While it can be used for confirmation, it's not the most commonly used primary diagnostic tool (which is often **ultrasound** or **MRI** with specific contrast patterns), and GI bleeding is a more direct application where the scan detects extravasation rather than vascular pooling.
Explanation: ***Technetium-99m linked to Methylene diphosphonate*** - **Technetium-99m MDP** is the most widely used radiopharmaceutical for skeletal imaging due to its **high affinity for hydroxyapatite crystals** in bone and favorable physical properties. - It readily incorporates into areas of **increased bone turnover**, making it excellent for detecting fractures, infections, and metastatic lesions. *Gallium 67* - **Gallium 67** is primarily used for **oncology, infection, and inflammation imaging** and has limited utility for general skeletal imaging. - It accumulates in areas of infection and inflammation, but its **biodistribution is not specific for bone metabolism**. *Technetium-sulfur-colloid* - **Technetium-sulfur-colloid** is mainly used for **liver and spleen imaging** (reticuloendothelial system), not for bone scans. - Its particle size and chemical properties prevent its significant uptake in bone tissue. *Technetium-99m* - **Technetium-99m** is a **radioisotope generator** for many different radiopharmaceuticals, but by itself, it's not directly used for skeletal imaging. - It serves as the **radionuclide scaffold** that is chelated to specific bone-seeking ligands like MDP.
Explanation: ***18FDG PET Scan*** - This patient, presenting with new neurological symptoms after **surgery and radiotherapy** for a cerebral tumor, faces a diagnostic dilemma: differentiating between **tumor recurrence** and **radiation necrosis**. - **18FDG PET scans** effectively distinguish between these two conditions because viable tumor cells exhibit high metabolic activity and thus actively take up **fluorodeoxyglucose (FDG)**, while radiation necrosis is metabolically inactive and shows little to no FDG uptake. *Digital subtraction angiography with dual source CT scan* - **Digital subtraction angiography (DSA)** is primarily used to visualize **vascular structures** and is not the modality of choice for differentiating tumor recurrence from radiation necrosis. - A **dual-source CT scan** is useful for rapid imaging and dynamic studies but lacks the metabolic information needed for this specific differentiation. *Gd-enhanced MRI* - While **Gd-enhanced MRI** is excellent for detecting **structural changes** and **blood-brain barrier disruption**, it often cannot definitively differentiate between **tumor recurrence** and **radiation necrosis**. - Both conditions can present with similar **enhancement patterns** on MRI, making differentiation challenging without additional metabolic information. *99Tc-HMPAO SPECT brain* - **99mTc-HMPAO SPECT** measures **regional cerebral blood flow (rCBF)**, which can be altered in both tumors and areas of radiation injury. - However, it does not provide the specific metabolic information (glucose metabolism) needed to reliably distinguish between **viable tumor cells** and **radiation necrosis** as effectively as FDG PET.
Explanation: ***Fluorine 18*** - **18F-FDG** (Fluorodeoxyglucose) is the most common PET tracer, utilizing **Fluorine-18** as its radioactive component. - FDG is a glucose analog, meaning it mimics glucose and is taken up by metabolically active cells, allowing for imaging of **glucose metabolism**. *Aluminum - 12* - **Aluminum-12** is not a common radionuclide used in PET imaging. - The most common tracers in PET are **positron emitters** like Fluorine-18, Carbon-11, Nitrogen-13, and Oxygen-15. *Carbon 11* - **Carbon-11** can be used in PET tracers (e.g., 11C-methionine), but it is **less common** than 18F-FDG due to its shorter half-life. - Its short half-life (20 minutes) requires an **on-site cyclotron** for production, limiting its widespread use. *Oxygen 15* - **Oxygen-15** is employed in PET tracers (e.g., 15O-water for cerebral blood flow), but it has an **even shorter half-life** (2 minutes) than Carbon-11. - Its extremely short half-life makes it **impractical** for routine clinical use in the form of a glucose sugar.
Explanation: ***Tc-99m Pyrophosphate*** - This radioisotope binds to **calcium deposits** in infarcted myocardial tissue, which accumulate 12-24 hours after injury. - It is particularly useful for detecting **acute myocardial infarction** (hot spot imaging) when cardiac biomarkers may be unreliable or in cases of delayed presentation. - Shows positive uptake in necrotic tissue, making it a "positive" or "hot spot" agent for acute MI. *Thallium 201* - **Thallium 201** is a potassium analog that is actively transported into viable myocardial cells. - It is primarily used for assessing **myocardial perfusion** and viability, showing areas of reduced blood flow or scar tissue. - Acts as a "cold spot" agent - infarcted areas show reduced uptake. *Tc-99m Sestamibi* - **Tc-99m Sestamibi** is a commonly used tracer for **myocardial perfusion imaging (SPECT)**, indicating blood flow to the heart muscle. - It accumulates in viable myocardial cells in proportion to blood flow and is not specific for acute myocardial necrosis. - Used primarily for stress testing and perfusion assessment, not acute infarct detection. *18-FDG PET* - **18-FDG PET** (Fluorodeoxyglucose Positron Emission Tomography) primarily measures **glucose metabolism** in the myocardium. - It is predominantly used to assess **myocardial viability** in areas of hibernating myocardium rather than acute infarction. - Helps distinguish viable but ischemic tissue from scar tissue.
Explanation: ***DTPA renogram*** - A **DTPA (diethylenetriamine pentaacetic acid) renogram** is a nuclear medicine study that assesses **renal blood flow**, **glomerular filtration**, and urinary drainage. It directly measures the function of each kidney by quantifying tracer uptake and excretion, making it ideal for diagnosing a non-functioning kidney in a child. - The test provides information on the **relative function** of each kidney and outflow obstruction, which is crucial for determining if a kidney is truly non-functioning rather than just poorly visualized. *Ultrasonography* - While ultrasound can visualize the **anatomy** of the kidney (size, shape, presence of hydronephrosis), it does not directly assess renal function. - It may show a small, atrophic, or poorly developed kidney, but cannot definitively determine if it is non-functioning without functional studies. *IVU (Intravenous Urogram)* - An **IVU** relies on the kidneys' ability to excrete contrast material, which is visualized by X-ray. If a kidney is non-functioning, it will not excrete the contrast, leading to non-visualization. - However, IVU exposes the child to **radiation** and **iodinated contrast**, and newer, safer, and more precise functional studies like renograms are preferred, especially in pediatric cases where radiation exposure should be minimized. *Creatinine clearance* - **Creatinine clearance** is a measure of overall **glomerular filtration rate (GFR)** for both kidneys combined. - It does not provide information on the individual function of each kidney, so it cannot diagnose a non-functioning unilateral kidney.
Explanation: ***Regional wall perfusion*** - A MUGA scan assesses **ventricular function** through blood pool imaging, evaluating wall motion and ejection fraction. - It does not directly visualize or quantify myocardial perfusion, which is the flow of blood through the coronary arteries to the heart muscle. *Stroke volume* - A MUGA scan accurately measures **end-diastolic volume** and **end-systolic volume**, from which stroke volume (EDV – ESV) can be calculated. - This parameter directly reflects the amount of blood pumped out by the ventricle with each beat. *Left ventricular ejection fraction* - The MUGA scan is considered a gold standard for calculating **left ventricular ejection fraction** (LVEF), a key indicator of cardiac pump function. - It uses a count-based method from gated blood pool images to determine the percentage of blood ejected from the left ventricle. *Regional wall motion* - MUGA scans are highly effective in assessing **regional wall motion abnormalities**, identifying areas of **hypokinesis**, **akinesis**, or **dyskinesis**. - This is crucial for diagnosing and monitoring conditions like myocardial ischemia or infarction, and is a primary utility of the scan.
Explanation: ***Liver adenoma*** - Tc-labeled RBCs are primarily used to highlight a specific type of tissue or process. **Liver adenomas** do not typically show an affinity for **Tc-labeled RBCs**, as they are benign epithelial tumors with a different vascular composition. - While adenomas can be vascular, they do not inherently contain the **vascular pooling** or blood volume characteristics that would be specifically targeted by **Tc-labeled RBCs** for diagnostic imaging. *LV function* - **Tc-labeled RBCs** (or Tc-99m-pertechnetate) are commonly used in **gated blood pool imaging** (MUGA scan) to assess **left ventricular (LV) function**, including **ejection fraction** and wall motion abnormalities. - This technique directly visualizes the blood pool within the cardiac chambers, making it suitable for assessing functional parameters of the heart. *GI bleeding* - **Tc-labeled RBCs** are a standard imaging agent for detecting and localizing **active gastrointestinal (GI) bleeding**, especially when the bleeding rate is intermittent or slow. - The labeled RBCs extravasate at the site of hemorrhage, creating a 'hot spot' that can be identified over time. *Liver hemangioma* - **Tc-labeled RBCs** are highly effective in diagnosing **liver hemangiomas**, which are benign vascular tumors composed of large, dilated blood vessels. - These lesions show characteristic uptake and retention of **labeled RBCs** due to their slow blood flow and large intravascular space, appearing as early peripheral enhancement with subsequent centripetal filling.
Explanation: ***68Ga-DOTATATE PET/CT*** - **68Ga-DOTATATE PET/CT** is highly sensitive for detecting **neuroendocrine tumors**, including pheochromocytomas and paragangliomas, due to its affinity for **somatostatin receptors** which are overexpressed on these cells. - This modality offers superior sensitivity in localizing both adrenal and **extra-adrenal pheochromocytomas**, particularly in cases of metastatic disease or multifocal lesions. *USG* - **Ultrasound (USG)** has limited utility for localizing **extra-adrenal pheochromocytomas**, especially if they are small, located in less accessible anatomical sites, or obscured by bowel gas. - While useful for initial screening of adrenal masses, its sensitivity for **extra-adrenal disease** is low. *MRI* - **MRI** is a valuable imaging modality for pheochromocytoma localization, offering good soft tissue contrast, but its overall sensitivity for detecting **extra-adrenal lesions** may be surpassed by more specific functional imaging techniques like 68Ga-DOTATATE PET/CT. - It is particularly useful for assessing the extent of disease and anatomical proximity to vital structures once a lesion is identified, but less sensitive for identifying occult **extra-adrenal tumors**. *MIBG scan* - **MIBG scintigraphy** relies on the uptake of a chemical analog of norepinephrine by **sympathetic neurosecretory cells**, making it useful for detecting pheochromocytomas. - However, its sensitivity in detecting **extra-adrenal pheochromocytomas** and metastatic disease is generally lower compared to 68Ga-DOTATATE PET/CT, particularly for certain genetic subtypes.
Explanation: ***Needle insertion in 2nd intercostal space, midclavicular line*** - The combination of **dyspnea**, **absent breath sounds** on one side, and **hypotension** points to a **tension pneumothorax**, which is a medical emergency. - **Needle decompression** at the 2nd intercostal space, midclavicular line is the immediate life-saving intervention to relieve the pressure. *Chest X-ray* - While a Chest X-ray would confirm the diagnosis, it would **delay the urgent intervention** required for a tension pneumothorax. - The clinical picture dictates immediate treatment rather than diagnostic confirmation when a life-threatening condition is suspected. *Intubate the patient* - **Intubation** is not the primary treatment for a tension pneumothorax; it addresses airway compromise but not the underlying lung collapse and mediastinal shift. - It might even worsen the condition if **positive pressure ventilation** is applied before decompression. *Urgent IV fluid administration* - **IV fluids** are important for managing hypotension, but they do not address the **mechanical compression** of the heart and good lung by the tension pneumothorax. - Without relieving the tension, fluid administration alone will not improve the patient's cardiorespiratory status.
Get full access to all questions, explanations, and performance tracking.
Start For Free